1Xu D, Thiele GM, Beckenhauer JL, et al. Detection of circulation antibody to malondialdehyde-acetaldehyde adducts in ethanol-fed rats. Gastroenterology, 1998, 115:686-692.
2Grove J, Brown AS, Daly AK, et al. The RSAI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype. Pharmacogenetics, 1998, 8:335-342.
3Grove J, Daly AK, Bassendine MF, et al. Association of a tumor necrosis factor polymorphism with susceptibility to alcoholic steatohepatitis.Hepatology, 1997, 26:143-146.
4Rouault TA, Klausner RD. Iron-sulfur clusters as biosensors of oxidants and iron. Trends Biochem Sci, 1996, 21:174-177.
5Vorobioff J, Groszmann RJ, Picabea E, et al. Prognostic value of hep atic venous pressure gradient measurements in alcoholic cirrhosis: a 10year prospective study. Gastroenterology, 1996,11 1: 701-709.
6Garbutt JC, West SL, Carey TS, et al. Pharmacological treatment of alcohol dependence. JAMA, 1999,281:1318-1325.
7Chataway J, Hardman E. Thiamiene in Wernicke' s syndrome--how much and how long? Postgrad Med J, 1995,71:249.
8Imperale T, McCullough A. Do corticosteroids reduced mortality from alcoholic hepatitis? Ann Intern Med, 1990,113:299-303.
9Nanji AA, Sadrzadeh SM, Yand EK, et al. Dietary saturated fatty acids: a novel treatment for alcoholic liver disease. Gastroenterology,1995, 109:547-554.
